This article is educational and does not replace medical advice. Prescription medication requires review by a licensed clinician and, when appropriate, a valid prescription. Compounded medications are not FDA-approved, and the FDA does not verify their safety, effectiveness or quality before marketing. Treatment eligibility is an individual clinical decision.
Released: ·Last reviewed: ·Methodology v4.1
This page is maintained. Prices are re-read at source and dated; evidence is checked against the published trial. Newest across the site: news · research · corrections.
Best peptide telehealth programs: our standard
We do not publish a peptide provider ranking built on marketing claims. This page explains the standard a peptide program must meet to earn a recommendation, and links to the verification tools.
Quick answer
A recommendable peptide program requires licensed clinician oversight, a licensed dispensing pharmacy, honest regulatory disclosure, and evidence-based claims. Until providers clear that bar with verified evidence, we publish the standard rather than a ranking.
Where should you read next?
Verify a peptide provider
Checklist
Peptide therapy overview
How it works
Tesamorelin
An FDA-approved peptide
Sources
- U.S. Food and Drug Administration — approval and compounding status.
- Primary clinical literature cited on child pages.
- Our methodology and source standards.
How the dates on this page work. Manufacturer self-pay prices were re-read on 15 October 2026: NovoCare’s Wegovy page and Lilly’s Zepbound savings page. Foundayo prices are carried from LillyDirect pages archived 25 September 2026, because lilly.com blocked automated reads. Figures captured from telehealth provider websites carry the date we read that provider’s page, which may be earlier; where it is, the row or a dated notice says so. We do not restamp a figure we have not re-read.